GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (OTCPK:DOSEF) » Definitions » LT-Debt-to-Total-Asset

DOSEF (Doseology Sciences) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Doseology Sciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Doseology Sciences's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.00.

Doseology Sciences's long-term debt to total assets ratio stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00).


Doseology Sciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for Doseology Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doseology Sciences LT-Debt-to-Total-Asset Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
LT-Debt-to-Total-Asset
- 0.11 0.17 0.01 -

Doseology Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Doseology Sciences LT-Debt-to-Total-Asset Calculation

Doseology Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (A: Jun. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2024 )/Total Assets (A: Jun. 2024 )
=0/0.804
=0.00

Doseology Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=0/0.686
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doseology Sciences  (OTCPK:DOSEF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Doseology Sciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Doseology Sciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Doseology Sciences Business Description

Traded in Other Exchanges
Address
9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.

Doseology Sciences Headlines

From GuruFocus

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-11-2022

Doseology Opens to American Investors

By PRNewswire PRNewswire 07-01-2022

Doseology Opens to American Investors

By PRNewswire PRNewswire 07-11-2022

Doseology Announces CEO Transition

By PRNewswire PRNewswire 03-31-2023

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-01-2022

Doseology Provides Corporate Update

By PRNewswire PRNewswire 01-23-2023

Doseology Uplists to OTCQB Market in USA

By PRNewswire PRNewswire 07-06-2022

Doseology Announces New Director and Corporate Secretary

By PRNewswire PRNewswire 05-05-2023

Doseology Welcomes New CFO

By PRNewswire PRNewswire 03-03-2023